Bär & Karrer is a leading Swiss law firm with more than 200 lawyers in Zurich, Geneva, Lugano, Zug, Basel and St. Moritz. Our core business is advising our clients on innovative and complex transactions and representing them in litigation, arbitration and regulatory proceedings. Our clients range from multinational corporations to private individuals in Switzerland and around the world. Most of our work has an international component. We have broad experience handling cross-border proceedings and transactions. Our extensive network consists of correspondent law firms which are all market leaders in their jurisdictions. Bär & Karrer was repeatedly awarded Switzerland Law Firm of the Year by the most important international legal ranking agencies in recent years.
Switzerland's 2025 healthcare law outlines a complex regulatory framework for medical devices, pharmaceuticals, cosmetics, biocides, and emerging technologies like AI and mHealth.
In Switzerland, the regulatory landscape governing medicinal
products, medical devices, consumer healthcare products, food and
nutritional supplements, tobacco, cannabidiol products, cosmetics,
biocides, and emerging technologies, such as mobile health, medical
apps, wearables, and telemedicine, is highly fragmented. It spans a
complex web of statutes, ordinances, guidelines, and international
regulations. Navigating these diverse product categories and their
intricate regulatory requirements, often marked by nuanced
delimitation challenges, requires not only deep legal and
regulatory expertise but also substantial practical industry
experience. Recent advances in artificial intelligence have further
shaped this dynamic field. This article offers an overview of the
relevant Swiss regulations, highlights key challenges and pitfalls,
and discusses notable recent developments.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
